Of course, your doctor can also provide you with personalized recommendations to help you achieve your weight-loss goals
Given the increasing availability of CV safety outcomes data for glucose-lowering medications, it has become apparent that certain agents within the GLP-1RA and SGLT-2 inhibitor classes reduce the risk of CV events in those with high-risk CV or CKD [16,17,18,19,20,21]
The right question isn't "GLP-1 or statin." It's recognizing that we may now have two largely independent levers on cardiovascular risk, and the evidence supports using both, not choosing between them
Strict research-only chemical
In particular, GSTT1-1 and GSTM1-1 null genotypes, as well as GSTP1-1 variants, were studies and showed a positive correlation with cancer risk (Table 1) 24,32,35,36,37,38,39,40,41,42
An ton cho sc khe v khng gy tc dng ph ng k